Jim Simons Castle Biosciences Inc Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 670,500 shares of CSTL stock, worth $15.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

670,500

Previous 701,200 4.38%

Holding current value

$15.1 Million

Previous $14 Million 2.47%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$15.8 - $21.98 $485,060 - $674,786	-30,700 Reduced 4.38%	670,500 $13.7 Million
Q1 2025 May 14, 2025	BUY	$18.76 - $32.72 $303,912 - $530,064	16,200 Added 2.36%	701,200 $14 Million
Q4 2024 Feb 13, 2025	BUY	$26.52 - $34.67 $5.18 Million - $6.78 Million	195,438 Added 39.92%	685,000 $18.3 Million
Q3 2024 Nov 13, 2024	BUY	$17.4 - $31.47 $3.27 Million - $5.92 Million	188,062 Added 62.38%	489,562 $14 Million
Q2 2024 Aug 09, 2024	BUY	$18.84 - $24.94 $1.82 Million - $2.41 Million	96,800 Added 47.29%	301,500 $6.56 Million
Q1 2024 May 13, 2024	BUY	$18.06 - $25.3 $1.67 Million - $2.34 Million	92,300 Added 82.12%	204,700 $4.53 Million
Q4 2023 Feb 13, 2024	BUY	$12.19 - $22.43 $68,264 - $125,608	5,600 Added 5.24%	112,400 $2.43 Million
Q3 2023 Nov 14, 2023	SELL	$13.28 - $20.3 $871,168 - $1.33 Million	-65,600 Reduced 38.05%	106,800 $1.8 Million
Q2 2023 Aug 11, 2023	BUY	$11.66 - $26.0 $1.59 Million - $3.54 Million	136,000 Added 373.63%	172,400 $2.37 Million
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $278,421 - $407,407	14,300 Added 64.71%	36,400 $827,000
Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $92,207 - $153,000	5,100 Added 30.0%	22,100 $520,000
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $9,004 - $13,728	-400 Reduced 2.3%	17,000 $443,000
Q2 2022 Aug 12, 2022	SELL	$16.0 - $45.99 $121,600 - $349,524	-7,600 Reduced 30.4%	17,400 $382,000
Q1 2022 May 13, 2022	SELL	$33.17 - $46.98 $3.62 Million - $5.13 Million	-109,281 Reduced 81.38%	25,000 $1.12 Million
Q4 2021 Feb 11, 2022	BUY	$39.06 - $67.58 $5.25 Million - $9.07 Million	134,281 New	134,281 $5.76 Million
Q2 2021 Aug 13, 2021	SELL	$50.07 - $76.78 $1.38 Million - $2.11 Million	-27,500 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$58.92 - $97.33 $1.62 Million - $2.68 Million	27,500 New	27,500 $1.88 Million
Q4 2020 Feb 10, 2021	SELL	$43.6 - $73.05 $170,040 - $284,895	-3,900 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$38.47 - $52.03 $1.5 Million - $2.03 Million	-38,936 Reduced 90.9%	3,900 $201,000
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $262,870 - $414,444	9,636 Added 29.02%	42,836 $1.61 Million
Q1 2020 May 14, 2020	BUY	$23.08 - $35.53 $766,256 - $1.18 Million	33,200 New	33,200 $990,000

Others Institutions Holding CSTL

# of Institutions

165

Shares Held

27.2M

Call Options Held

Put Options Held

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $592M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account